StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)

Close on Nov 18, 2026Market cap $3.04BP/E –Yield –

Telix Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $803.79M, up 55.6% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$803.79M+55.6%
FY2024Dec 31, 2024$516.55M+55.1%
FY2023Dec 31, 2023$332.98M–

More Telix Pharmaceuticals figures

See a number that looks wrong?